Company Snapshot
- Ticker
- ABT
- Name
- ABT
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 214339950000.000000
- Volume
- 6,713,827
- Avg Volume (3M)
- 5,956,514
ABT
ABT
Last update recent
122.55
+1.30
(+1.07%)
Market Cap
214339950000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 43843000000.000000
- EPS
- 8.05
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 1.89%
- Net Income
- 13977000000.000000
- Net Margin
- 31.88%
- Payout Ratio
- 28.93%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 15.34
- Forward P/E
- None
- P/S
- 4.89
- P/B
- 4.18
- Beta
- None
- Debt / Equity
- 0.25
- Current Ratio
- 1.70
- Return on Equity
- 0.27%
- Return on Assets
- 0.17%
Technicals & Returns
- Distance vs 200 DMA
- -5.61%
- 200 DMA
- 129.84
- Distance vs 50 DMA
- -4.12%
- 50 DMA
- 127.82
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's dis Read more
- Name
- ABT
- Industry
- Medical - Devices
- CEO
- Mr. Robert B. Ford
- Employees
- 114,000
- IPO Date
- 1980-03-17
- Phone
- 224 667 6100
- Address
- None
- Website
- https://www.abbott.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-07-15 • $0.55
Latest News
Curated headlines from premium sources.
Why the Market Dipped But Abbott (ABT) Gained Today
The latest trading day saw Abbott (ABT) settling at $128.47, representing a +2.4% change from its previous close.
Abbott Gains From Lingo CGM's Expansion on Android Platform
ABT expands its Lingo biowearable to Android, broadening access to real-time glucose tracking and pushing continuous monitoring into mainstream wellness.
Corient Private Wealth LLC Increases Holdings in Abbott Laboratories $ABT
Corient Private Wealth LLC grew its holdings in Abbott Laboratories (NYSE: ABT) by 10.4% during the second quarter, according to the company in its most recent…
Start the New Year Off With Passive Income: 3 Dividend Kings to Buy Now
Dividend stocks may boost your portfolio during any market environment. These particular companies have shown their commitment to dividend payments and growth …
My Top 10 Stocks to Buy for 2026
Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many are leaders in their markets.
Ameriprise Financial Inc. Grows Stock Holdings in Abbott Laboratories $ABT
Ameriprise Financial Inc. increased its position in shares of Abbott Laboratories (NYSE: ABT) by 7.8% during the undefined quarter, according to the company in…